Xiaojun Xia

6.4k citations

121 papers · 4.0k indexed · 2 hit papers · h-index 29

Impact in

Immunology top 1%
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Cancer Research top 2%
- NF-κB Signaling Pathways

Papers in ⓘ

Immunology 42
- Immunotherapy and Immune Responses 16
- Immune cells in cancer 10
- interferon and immune responses 10
- Immune Cell Function and Interaction 8
Cancer Research 18
- NF-κB Signaling Pathways 10

Co-authors: Peng Huang (14 shared papers)Jinyun Liu (9 shared papers)Jun Cui (8 shared papers)Xiaojuan Wang (13 shared papers)Rong‐Fu Wang (5 shared papers)Helen Y. Wang (4 shared papers)Jun Ki Hong (2 shared papers)Zhijian J. Chen (2 shared papers)
Journals: Cancer Research (4 papers)Advanced Science (4 papers)Clinical Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Immunity (3 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Xiaojun Xia

111 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Recent progress in mRNA cancer vaccines 2024 · 58 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Human Vaccines & Immunotherapeutics
2021 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Xiaojun Xia

Since Specialization

Citations

This map shows the geographic impact of Xiaojun Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Xia more than expected).

Fields of papers citing papers by Xiaojun Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Xia. The network helps show where Xiaojun Xia may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaojun Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaojun Xia Line = papers co-authored together Xiaojun Xia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways Cell ·Jun Cui, Liang Zhu, Xiaojun Xia, Helen Y. Wang, Xavier Legras, Jun Ki Hong, Jiabing Ji, Pingping Shen, Shu Zheng, Zhijian J. Chen, Rong‐Fu Wang	2010	361
2	xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling Molecular Therapy ·Jinyun Liu, Xiaojun Xia, Peng Huang	2020	243
3	NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK Immunity ·Xiaojun Xia, Jun Cui, Helen Y. Wang, Liang Zhu, Satoko Matsueda, Qinfu Wang, Xiaoang Yang, Jun Ki Hong, Zhou Songyang, Zhijian J. Chen, Rongfu Wang	2011	235
4	Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling Proceedings of the National Academy of Sciences ·Hongxia Zhang, Xinru You, Xiaojuan Wang, Lei Cui, Zining Wang, Feifei Xu, Mengyun Li, Zhenggang Yang, Jinyun Liu, Peng Huang, Yang Kang, Jun Wu, Xiaojun Xia Hit paper breakdown →	2021	213
5	cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity Journal of Clinical Investigation ·Zining Wang, Jiemin Chen, Jie Hu, Hongxia Zhang, Feifei Xu, Wenzhuo He, Xiaojuan Wang, Mengyun Li, Wenhua Lu, Gucheng Zeng, Penghui Zhou, Peng Huang, Siyu Chen, Wende Li, Liangping Xia, Xiaojun Xia	2019	185
6	USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy Cellular and Molecular Immunology ·Tao Liu, Liqiu Wang, Puping Liang, Xiaojuan Wang, Yukun Liu, Jing Cai, Yuanchu She, Dan Wang, Zhi Wang, Zhiyong Guo, Samuel Bates, Xiaojun Xia, Junjiu Huang, Jun Cui	2020	169
7	Designing Bioinspired 2D MoSe₂ Nanosheet for Efficient Photothermal‐Triggered Cancer Immunotherapy with Reprogramming Tumor‐Associated Macrophages Advanced Functional Materials ·Lizhen He, Tianqi Nie, Xiaojun Xia, Ting Liu, Yanyu Huang, Xiaojuan Wang, Tianfeng Chen	2019	168
8	USP 19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin‐1 The EMBO Journal ·Shouheng Jin, Shuo Tian, Yamei Chen, Chuanxia Zhang, Weihong Xie, Xiaojun Xia, Jun Cui, Rong‐Fu Wang	2016	146
9	TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils Immunity ·Adebusola Alagbala Ajibade, Qinfu Wang, Jun Cui, Jia Zou, Xiaojun Xia, Mingjun Wang, Yanzheng Tong, Hui Wei, Dou Liu, Bing Su, Helen Y. Wang, Rong‐Fu Wang	2012	134
10	Single-cell transcriptome profiling of an adult human cell atlas of 15 major organs Genome biology ·Shuai He, Lin-he Wang, Yang Liu, Yiqi Li, Hai-Tian Chen, Jing-hong Xu, Peng Wan, Guo-Wang Lin, Pan-Pan Wei, Bo Li, Xiaojun Xia, Dan Wang, Jin‐Xin Bei, Xiaoshun He, Zhiyong Guo	2020	126
11	SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy Clinical Cancer Research ·Feng Wang, Xiaojun Xia, Chunying Yang, Jianliang Shen, Junhua Mai, Han-Cheon Kim, Dickson Kirui, Ya’an Kang, Jason B. Fleming, Eugene J. Koay, Sankar Mitra, Mauro Ferrari, Haifa Shen	2018	123
12	Automatic Detection and Classification of Steel Surface Defect Using Deep Convolutional Neural Networks Metals ·Shuai Wang, Xiaojun Xia, Lanqing Ye, B. Yang	2021	105
13	IKKα Is Required to Maintain Skin Homeostasis and Prevent Skin Cancer Cancer Cell ·Bigang Liu, Xiaojun Xia, Feng Zhu, Eunmi Park, Steve Carbajal, Kaoru Kiguchi, John DiGiovanni, Susan M. Fischer, Yinling Hu	2008	99
14	High Capacity Nanoporous Silicon Carrier for Systemic Delivery of Gene Silencing Therapeutics ACS Nano ·Jianliang Shen, Rong Xu, Junhua Mai, Han-Cheon Kim, Xiaojing Guo, Guoting Qin, Yong Yang, Joy Wolfram, Chaofeng Mu, Xiaojun Xia, Jianhua Gu, Xuewu Liu, Zong‐Wan Mao, Mauro Ferrari, Haifa Shen	2013	96
15	Porous Silicon Microparticle Potentiates Anti-Tumor Immunity by Enhancing Cross-Presentation and Inducing Type I Interferon Response Cell Reports ·Xiaojun Xia, Junhua Mai, Rong Xu, Jorge Enrique Tovar Perez, María L. Guevara, Qi Shen, Chaofeng Mu, Hui-Ying Tung, David B. Corry, Scott E. Evans, Xuewu Liu, Mauro Ferrari, Zhiqiang Zhang, Li X, Rong‐Fu Wang, Haifa Shen	2015	78
16	Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling Redox Biology ·Christophe Glorieux, Xiaojun Xia, Yong-Qiao He, Yumin Hu, Kelly Cremer, Annie Robert, Junchen Liu, Fen Wang, Jianhua Ling, Paul J. Chiao, Peng Huang	2020	60
17	Recent progress in mRNA cancer vaccines Human Vaccines & Immunotherapeutics ·Ruhui Yao, C. Xie, Xiaojun Xia Hit paper breakdown →	2024	58
18	Reduction in IκB Kinase α Expression Promotes the Development of Skin Papillomas and Carcinomas Cancer Research ·Eunmi Park, Feng Zhu, Bigang Liu, Xiaojun Xia, Jianjun Shen, Tracie Bustos, Susan M. Fischer, Yinling Hu	2007	56
19	IKKα Shields 14-3-3σ, a G2/M Cell Cycle Checkpoint Gene, from Hypermethylation, Preventing Its Silencing Molecular Cell ·Feng Zhu, Xiaojun Xia, Bigang Liu, Jianjun Shen, Yuhui Hu, Maria D. Person, Yinling Hu	2007	55
20	Multistage Vectored siRNA Targeting Ataxia‐Telangiectasia Mutated for Breast Cancer Therapy Small ·Rong Xu, Yi Huang, Junhua Mai, Guodong Zhang, Xiaojing Guo, Xiaojun Xia, Eugene J. Koay, Guoting Qin, Donald R. Erm, Qingpo Li, Xuewu Liu, Mauro Ferrari, Haifa Shen	2013	55

About Xiaojun Xia

Xiaojun Xia is a scholar working on Immunology, Cancer Research, Oncology, Molecular Biology and Industrial and Manufacturing Engineering, having authored 121 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (16 papers), RNA Interference and Gene Delivery (12 papers), NF-κB Signaling Pathways (10 papers), Immune cells in cancer (10 papers), interferon and immune responses (10 papers), Immune Cell Function and Interaction (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Immunology (1.6k citations), Cancer Research (752 citations), Oncology (832 citations), Molecular Biology (2.0k citations) and Biomaterials (204 citations). Xiaojun Xia has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Peng Huang, Jinyun Liu, Jun Cui, Xiaojuan Wang, Rong‐Fu Wang, Helen Y. Wang, Jun Ki Hong, Zhijian J. Chen, Liang Zhu and Hongxia Zhang. Their work appears in journals such as Cancer Research, Advanced Science, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact